Page 9 of 12
The Journal of Organic Chemistry
132.4, 130.4, 125.2, 125.0, 72.0, 39.4, 34.4, 31.4, 25.1, 19.3;
been reported.42 The material obtained from this method
provided an identical 1H NMR. An image of the 1H NMR spec-
trum is supplied in the accompanying file.
IR (KBr, thin film, cm-1) 3050, 2817, 1571, 1401, 1161;
HRMS (ESI-TOF) m/z: [M + Na]+ calcd for C16H22ONa+
253.1563, found 253.1574. Using ice bath cooling, rac-30c
(0.26 g, 79%) was isolated as an oil: 1H NMR (400 MHz,
CD3CN) δ 7.42 (s, 4H), 6.12 (dt, J = 3.8, 1.8 Hz, 1H), 4.19 –
4.13 (m, 1H), 2.58 – 2.46 (m, 1H), 2.46 – 2.36 (m, 1H), 1.95
– 1.85 (m, 2H), 1.84 – 1.67 (m, 2H), 1.33 (s, 9H); 13C NMR
(126 MHz, CD3CN) δ 150.8, 142.1, 138.1, 125.3, 125.1, 120.6,
56.9, 34.1, 30.5, 28.0, 26.9, 19.5; IR (KBr, thin film, cm-1)
2960, 2866, 2093, 1162; HRMS (CI-TOF) m/z: [M - N3]+ calcd
for C16H21+ 213.1638, found 213.1631.
1
2
3
4
5
6
7
8
9
(4-azidopent-2-en-2-yl)benzene (26). Following the azide
formation procedure above for compound 30e, the product
(0.24 g, 57%) was isolated as an oil: 1H NMR (500 MHz,
CDCl3) (E-isomer)δ 7.47 – 7.42 (m, 2H), 7.40 – 7.35 (m, 2H),
7.33 – 7.30 (m, 1H), 5.73 (dq J = 9.0, 1.5 Hz, 1H), 4.49 (dq, J
= 9.0, 6.6 Hz, 1H), 2.17 (d, J = 1.4 Hz, 3H), 1.37 (d, J = 6.6 Hz,
3H); 1H NMR (500 MHz, CDCl3) (Z-isomer) δ 7.50 – 7.15 (m,
5H), 5.47 (dq, J = 9.9, 1.6 Hz, 1H), 4.04 (dq, J = 9.9, 6.6 Hz,
1H), 2.12 (d, J = 1.4 Hz, 4H), 1.24 (d, J = 6.6 Hz, 3H); 13C NMR
(125 MHz, CDCl3) (E-isomer) δ 142.5, 139.3, 128.3, 127.6,
126.7, 126.0, 55.5, 20.7, 16.6; 13C NMR (125 MHz, CDCl3) (Z-
isomer) δ 141.5, 140.7, 128.4, 127.7, 127.3, 126.2, 56.0,
25.7, 20.8; IR (KBr, thin film, cm-1) 2979, 2096, 1444, 1231;
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
5-azido-4'-fluoro-2,3,4,5-tetrahydro-1,1'-biphenyl (rac-
30d). Following the procedure above for compound 30e, 4'-
fluoro-3,4-dihydro-[1,1'-biphenyl]-1(2H)-ol (0.83 g, 68%)
1
was isolated as an oil. H NMR (400 MHz, CDCl3) δ 7.50 –
HRMS (CI-TOF) m/z: [M - N3]+ calcd for C11H13 145.1012,
7.42 (m, 2H), 7.02 (apparent triplet, J = 7.02, 2H), 6.04 (dt, J
= 10.1, 3.7 Hz, 1H), 5.76 (d, J = 10.0, 1H), 2.23 (s, 1H), 2.19 –
2.03 (m, 2H), 2.02 – 1.92 (m, 1H), 1.89 – 1.72 (m, 2H), 1.66
+
found 145.1005.
5-azido-4'-methoxy-2,3,4,5-tetrahydro-1,1'-biphenyl (rac-
30a). Following the procedure above for compound 30e, 4'-
methoxy-3,4-dihydro-[1,1'-biphenyl]-1(2H)-ol (3.0 g, 47%)
was isolated as a waxy solid. Characterization data for this
compound has been reported.63 The material obtained from
this method provided an identical 1H NMR spectrum. An im-
– 1.56 (m, 1H); 13C NMR (125 MHz, CDCl3) δ 161.8 (d, JC-F
=
243.3 Hz), 143.6 (d, JC-F = 3.0 Hz), 132.1, 130.9, 127.2 (d, JC-F
= 7.9 Hz), 114.7 (d, JC-F = 21.1 Hz), 71.9, 39.7, 25.0, 19.2; 19
F
NMR (376 MHz, CDCl3) δ -116.5; IR (KBr, thin film, cm-1)
3378, 2938, 1601, 1508, 1221, 1175, 833; HRMS (EI-TOF)
m/z: [M]+ calcd for C12H13FO+ 192.0945, found 192.0951.
The product rac-30d (0.17 g, 79%) was isolated as an oil:
1H NMR (400 MHz, CDCl3) δ 7.46 – 7.36 (m, 2H), 7.11 – 7.00
(m, 2H), 6.05 (dt, J = 3.6, 1.8 Hz, 1H), 4.14 – 4.08 (m, 1H),
2.55 – 2.35 (m, 2H), 2.03 – 1.90 (m, 2H), 1.88 – 1.74 (m, 2H);
13C NMR (125 MHz, CDCl3) δ 162.5 (d, JC-F = 245.3 Hz), 141.5,
1
age of the H NMR spectrum is supplied in the accompany-
ing file. With slight modifications, Cu(hfac)2 instead of
Zn(OTf)2 with ice bath cooling, the product rac-30a (0.58 g,
86%) was isolated as a waxy solid. 1H NMR (500 MHz,
CDCl3) δ 7.39 (d, J = 8.4 Hz, 2H), 6.91 (d, J = 8.5 Hz, 2H), 6.07
– 6.01 (m, 1H), 4.12 – 4.10 (m, 1H), 3.84 (s, 3H), 2.53 – 2.48
(m, 1H), 2.44 – 2.39 (m, 1H), 2.00 – 1.91 (m, 2H), 1.84 – 1.77
(m, 2H); 13C NMR (125 MHz, CDCl3) δ 159.4, 141.8, 133.5,
126.6, 119.8, 113.7, 57.0, 55.3, 28.4, 27.4, 19.8; IR (KBr, thin
film, cm-1) 2935, 2836, 2089, 1607, 1513, 1251, 1037; HRMS
(CI-TOF) m/z: [M - N3]+ calcd for C13H15O+ 187.1117, found
187.1110.
137.1 (d, JC-F = 3.4 Hz), 127.1 (d, JC-F = 7.8 Hz), 121.4 (d, JC-F
=
1.5 Hz), 115.2 (d, JC-F = 21.2 Hz), 56.8, 28.2, 27.5, 19.7; 19F
NMR (471 MHz, CDCl3) δ -114.6; IR (KBr, thin film, cm-1)
2940, 2096, 1601, 1510, 1231, 1161, 826; HRMS (CI-TOF)
m/z: [M - N3]+ calcd for C12H12F+ 175.0918, found 175.0924.
5-azido-4'-(trifluoromethyl)-2,3,4,5-tetrahydro-1,1'-bi-
phenyl (rac-30f). Following the procedure above for com-
pound 30e, 4'-(trifluoromethyl)-3,4-dihydro-[1,1'-bi-
phenyl]-1(2H)-ol (1.4 g, 78%) was isolated as an oil. Char-
acterization data for this compound has been reported.63
The material obtained from this method provided an iden-
tical 1H NMR spectrum. An image of the 1H NMR spectrum is
supplied in the accompanying file. The product rac-30f
(0.42 g, 83%) was isolated as an oil: 1H NMR (500 MHz,
CD3CN) δ 7.69 (d, J = 8.3 Hz, 2H), 7.64 (d, J = 8.5 Hz, 2H), 6.24
(dt, J = 3.8, 1.8 Hz, 1H), 4.23 – 4.17 (m, 1H), 2.56 – 2.50 (m,
1H), 2.47 – 2.41 (m, 1H), 2.05 – 1.95 (m, 1H), 1.95 – 1.86 (m,
1H), 1.84 – 1.72 (m, 2H); 13C NMR (125 MHz, CD3CN) δ
144.9, 141.0, 128.8 (q, JC-F = 32.0 Hz), 126.0, 125.8, 125.3 (q,
JC-F = 3.7 Hz), 124.5 (q, JC-F = 269.4 Hz), 56.7, 27.8, 26.8, 19.4;
19F NMR (471 MHz, CD3CN) δ -63.0; IR (KBr, thin film, cm-1)
2934, 2836, 2091, 1606, 1513, 1250, 1181; HRMS (CI-TOF)
m/z: [M - N3]+ calcd for C13H12F3+ 225.0886, found 225.0875.
5-azido-4'-methyl-2,3,4,5-tetrahydro-1,1'-biphenyl (rac-
30b). Following the above procedure for compound 30e, 4'-
methyl-3,4-dihydro-[1,1'-biphenyl]-1(2H)-ol (3.9 g, 68%)
was isolated as an oil. Characterization data for this com-
pound has been reported.63 The material obtained from this
method provided and identical 1H NMR spectrum. An image
1
of the H NMR spectrum is supplied in the accompanying
file. The product rac-30b (0.53 g, 71%) was isolated as an
1
oil: H NMR (400 MHz, CD3CN) δ 7.41 – 7.34 (d, J = 8.3 Hz,
2H), 7.19 (d, J = 8.0 Hz, 2H), 6.10 (dt, J = 3.8, 1.8 Hz, 1H), 4.18
– 4.14 (m, 1H), 2.56 – 2.36 (m, 2H), 2.35 (s, 3H), 1.95 – 1.85
(m, 2H), 1.83 – 1.71 (m, 2H); 13C NMR (125 MHz, CD3CN) δ
142.1, 138.1, 137.7, 129.0, 125.2, 120.5, 56.9, 28.0, 26.9,
20.1, 19.5; IR (KBr, thin film, cm-1) 2939, 2864, 2093, 1235;
HRMS (CI-TOF) m/z: [M - N3]+ calcd for C13H15 171.1168,
found 171.1166.
+
5-azido-4'-(tert-butyl)-2,3,4,5-tetrahydro-1,1'-biphenyl
(rac-30c). Following the procedure above for compound
30e, 4'-(tert-butyl)-3,4-dihydro-[1,1'-biphenyl]-1(2H)-ol
(1.3 g, 72%) was isolated as an oil: 1H NMR (400 MHz,
CDCl3) δ 7.45 (apparent d, J = 8.6 Hz, 2H), 7.39 (apparent d,
J = 8.6 Hz, 2H), 6.05 (dt, J = 10.0, 3.7 Hz, 1H), 5.82 (d, J = 10.1
Hz, 1H), 2.22 – 2.07 (m, 2H), 2.06 – 1.99 (m, 1H), 1.91 (td, J
= 10.0, 3.1 Hz, 1H), 1.87 – 1.77 (m, 1H), 1.69 – 1.61 (m, 1H),
1.36 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 149.7, 144.8,
5-methoxy-2,3,4,5-tetrahydro-1,1'-biphenyl (32e). This
procedure was adapted from a known method.64 To a solu-
tion of 3,4-dihydro-[1,1'-biphenyl]-1(2H)-ol (189 mg, 1.08
mmol) in MeCN (5 mL) and MeOH (1 mL) was added sali-
cylic acid (15 mg, 0.11 mmol). The resulting solution was
heated at 40 °C. After 18 h, the reaction was diluted with
ethyl acetate and quenched by the addition of saturated
aqueous NaHCO3. The resulting solution was extracted with
ACS Paragon Plus Environment